Indian J Pharm Sci. 2011 Jan;73(1):46-56. doi: 10.4103/0250-474X.89756.

Stability-indicating HPLC Method for Simultaneous Determination of Terbutaline Sulphate, Bromhexine Hydrochloride and Guaifenesin.

Indian journal of pharmaceutical sciences

A Porel, Sanjukta Haty, A Kundu

PMID: 22131621 PMCID: PMC3224409 DOI: 10.4103/0250-474X.89756

Abstract

The aim of the present study was the development and subsequent validation of a simple, precise and stability-indicating reversed phase HPLC method for the simultaneous determination of guaifenesin, terbutaline sulphate and bromhexine hydrochloride in the presence of their potential impurities in a single run. The photolytic as well as hydrolytic impurities were detected as 3,5-dihydroxybenzoic acid, 3,5-dihydroxybenzaldehyde, 1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl) amino]-ethanone from terbutaline, 2-methoxyphenol and an unknown impurity identified as (2RS)-3-(2-hydroxyphenoxy)-propane-1,2-diol from guaifenesin. The chromatographic separation of all the three active components and their impurities was achieved on Wakosil II column, using phosphate buffer (pH 3.0) and acetonitrile as mobile phase which was delivered initially in the ratio of 80:20 (v/v) for 18 min, then changed to 60:40 (v/v) for next 12 min, and finally equilibrated back to 80:20 (v/v) for 10 min. Other HPLC parameters were: Flow rate at 1.0 ml/min, detection wavelengths 248 and 280 nm, injection volume 10 μl. The calibration graphs plotted with five concentrations of each component were linear with a regression coefficient R(2) >0.9999. The limit of detection and limit of quantitation were estimated for all the five impurities. The established method was then validated for linearity, precision, accuracy, and specificity and demonstrated to be applicable to the determination of the active ingredients in commercial and model cough syrup. No interference from the formulation excipients was observed. These results suggest that this LC method can be used for the determination of multiple active ingredients and their impurities in a cough and cold syrup.

Keywords: Bromhexine hydrochloride; degradation products; guaifenesin; stability-indicating method; terbutaline sulfate; validation

References

1. J Pharm Biomed Anal. 2006 Jun 7;41(3):798-803 - PubMed
2. Talanta. 2009 May 15;78(3):991-7 - PubMed
3. J Chromatogr Sci. 1988 Dec;26(12):636-9 - PubMed
4. J Pharm Sci. 1979 Apr;68(4):530-2 - PubMed
5. J Pharm Biomed Anal. 2002 Jul 31;29(5):927-37 - PubMed
6. J Pharm Sci. 1983 Feb;72(2):196-8 - PubMed
7. J AOAC Int. 2008 Mar-Apr;91(2):276-84 - PubMed
8. J Pharm Sci. 1983 Jan;72(1):55-9 - PubMed
9. J Pharm Biomed Anal. 1996 Nov;15(2):287-93 - PubMed
10. J Chromatogr A. 2004 Sep 10;1048(2):207-11 - PubMed
11. Pak J Pharm Sci. 2008 Apr;21(2):151-8 - PubMed
12. Scand J Respir Dis. 1976;57(2):88-96 - PubMed
13. J Pharm Sci. 1980 Feb;69(2):212-4 - PubMed
14. J Pharm Biomed Anal. 2000 Oct;23(5):909-16 - PubMed

Publication Types

• Journal Article